<i>N</i>-(2-(1<i>H</i>-Indol-3-yl)ethyl)-2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide
Título
<i>N</i>-(2-(1<i>H</i>-Indol-3-yl)ethyl)-2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide
Autor
Stanimir Manolov, Iliyan Ivanov, Dimitar Bojilov
Descripción
N-(2-(1H-Indol-3-yl)ethyl)-2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide was prepared by a reaction between tryptamine and flurbiprofen, applying N,N’-dicyclohexylcarbodiimide, as a coupling agent. The obtained new amide has a fragment similar to Brequinar, a compound used in SARS-CoV-2 treatment trials. The newly synthesized compound was fully analyzed and characterized via 1H, 13C-NMR, UV, IR, and mass spectral data.
Fecha
2021
Materia
SARS-CoV-2, amide, tryptamine, Flurbiprofen
Identificador
10.3390/M1177
Fuente
Epidemiology and Health
Editor
Korean Society of Epidemiology
Cobertura
Inorganic chemistry
Colección
Citación
Stanimir Manolov, Iliyan Ivanov, Dimitar Bojilov, “<i>N</i>-(2-(1<i>H</i>-Indol-3-yl)ethyl)-2-(2-fluoro-[1,1′-biphenyl]-4-yl)propanamide,” SOCICT Open, consulta 20 de abril de 2026, https://socictopen.socict.org/items/show/7119.
Position: 10247 (25 views)